"The body’s own cells, given the right support, can help repair damage conventional treatment isn’t designed to reverse." This principle is driving a significant expansion in regenerative medicine, with companies like RejuvStem bringing advanced stem cell therapies closer to American patients.
Chronic pain affects a substantial portion of the American adult population, with nearly one in four individuals living with persistent discomfort. For those grappling with conditions affecting the spine and joints, treatment options have historically been limited to medication, physical therapy, or surgery. This narrow therapeutic landscape has spurred a burgeoning interest in regenerative medicine, a revolutionary field dedicated to harnessing the body’s innate healing capabilities. The core tenet of this approach is that by providing the right environment and support, the body’s own cells can be guided to repair damaged tissues and structures that traditional medical interventions often cannot fully restore. As this field gains momentum and regulatory landscapes evolve, with states like Florida actively expanding access to stem cell therapies, companies that have historically served American patients abroad are now strategically establishing their operational capacity within the United States.
Among these pioneering companies is RejuvStem, a prominent player in the regenerative medicine sector. The company currently operates two specialized clinics in Cancun, Mexico, and is on the cusp of launching Auragenesis Labs, Inc. This state-of-the-art stem cell manufacturing facility, situated near Miami, is the result of a strategic partnership with Longeveron and is anticipated to commence operations within the next one to two months. The establishment of Auragenesis Labs marks a significant milestone for RejuvStem, representing its inaugural manufacturing operation within the United States. Leading this ambitious expansion is John Merola, RejuvStem’s Chief Operating Officer and a key partner in the business. Merola’s own journey to the company is deeply personal and mirrors the experiences of many of its patients, as he initially sought RejuvStem’s services as an alternative to invasive surgical procedures.
Merola’s professional background prior to his involvement in regenerative medicine was rooted in real estate, where he collaborated closely with his father. Although he had secured admission to law school in Illinois, he ultimately chose to remain within the family business. The untimely death of his father, attributed to complications arising from high blood pressure and sleep apnea, profoundly influenced Merola’s perspective on his own career and the importance of addressing health issues proactively. This profound personal loss underscored for him the critical need for effective treatments that could prevent the debilitating health conditions his father endured.
In the years following his father’s passing, Merola himself began to experience significant chronic pain. He endured herniated and bulging discs, scoliosis, and a torn tricep, conditions that progressively limited his physical capabilities. The severity of his pain eventually reached a point where even simple activities, such as playing with his children on the floor, became impossible. Surgeons recommended spinal fusion, a complex and irreversible procedure. However, Merola harbored reservations about undergoing this surgery, having heard varied and sometimes discouraging accounts from individuals who had previously undergone the procedure.
It was a recommendation from a friend, WWE professional wrestler Ettore Ewen, widely known as Big E, that led Merola to explore alternative treatments. Ewen, who had previously received successful treatment at RejuvStem’s Cancun clinic, encouraged Merola to consider their approach before committing to surgery. Despite initial apprehension about seeking medical treatment outside of the United States, particularly given the limited availability of comparable options domestically at the time, Merola decided to proceed. He underwent stem cell injections targeting his spine, neck, and the tricep he had torn just a month prior.
"The next morning I was sitting on the balcony watching the sunrise, and I turned my neck without thinking about it," Merola recounted, reflecting on the transformative experience. "I hadn’t been able to do that in a long time. That was the moment everything changed for me." This profound personal recovery served as a powerful catalyst, prompting Merola to re-evaluate his professional trajectory and dedicate himself to a field that had so profoundly impacted his own life.
The success of his treatment led Merola to seek out RejuvStem’s founder, Chirag Shah. Shah had established the company five years prior, inspired by the remarkable recovery of a close friend who had experienced severe respiratory complications following COVID-19, a recovery attributed to similar regenerative therapies. Merola joined RejuvStem shortly thereafter as a partner, driven by a vision to extend such life-changing treatments to others. He often draws parallels between his father’s lived experience with untreated health issues and the patients he now serves, finding a deep sense of purpose in offering them hope and effective solutions.
RejuvStem’s origins trace back to Guadalajara, Mexico, before the company consolidated its clinical operations in Cancun approximately two years ago. The Cancun facilities are strategically divided: one clinic is dedicated to aesthetic treatments, while the second, located in Puerto Cancun, focuses exclusively on regenerative therapies administered through injection and intravenous protocols. The company positions itself as a global leader in DeZawa Muse cell treatments and asserts that its Mexican facility is the sole clinic worldwide offering both its proprietary human Regenerator technology and DeZawa Muse cell treatments. Furthermore, RejuvStem has forged a significant partnership with Micah Parsons of the Green Bay Packers, a collaboration that has amplified the company’s visibility and credibility within the professional sports community.
The newly established Miami lab represents a crucial step in separating RejuvStem’s manufacturing processes from its direct patient care operations. The lab is designed to produce and meticulously process stem cells, which are then administered to patients at partner clinics. RejuvStem’s innovative model involves deriving cells from donated placental tissue, obtained following consented, elective Cesarean section deliveries. These cells are then processed at the Auragenesis Labs facility and subsequently distributed to affiliated clinics. A key differentiator highlighted by Merola is the company’s commitment to delivering cells fresh, rather than frozen. RejuvStem posits that fresh cells offer superior consistency and potency compared to the cryogenically preserved products that are more prevalent across the regenerative medicine industry. However, Merola also acknowledges that individual patient outcomes can vary depending on a multitude of factors, including the specific condition being treated and the chosen therapeutic protocol.
The regulatory environment in Florida played a pivotal role in the company’s decision to establish its U.S. manufacturing hub there. The state’s forward-thinking approach to regenerative medicine has created a conducive environment for growth and innovation. Looking ahead, RejuvStem’s long-term strategy involves supplying its partner clinics not only within Florida but also in neighboring states such as Georgia and Tennessee. These states have enacted supportive legislation permitting allogeneic stem cell therapies at the state level, paving the way for broader patient access. For individuals residing in these markets, this expansion signifies the potential to receive advanced, fresh cell therapies without the necessity of international travel, an experience that was once a prerequisite for many, including Merola himself.
Merola now works in close collaboration with Chirag Shah, overseeing both the company’s clinical operations and its expansion into the U.S. market. Their daily communication is frequent, underscoring the depth of their partnership, which Merola describes as being more akin to a brotherhood than a purely business arrangement. This profound connection is underpinned by a shared and unwavering belief in the transformative potential of the work they are undertaking at RejuvStem.
